1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. THESEUS PHARMACEUTICALS INC

Theseus Pharmaceuticals Inc

XNAS: THRX

Watchlist

Portfolio

Share


Insider Trading disclosures for Theseus Pharmaceuticals Inc

The latest disclosure was made by Carl L. Gordon in Theseus Pharmaceuticals Inc where a trade of 328,482 Common Stock done at an average price of $3.0 was reported to US exchanges on July 17, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.05 per share. 17 Jul 2023 328,482 17,063,000 - 3.0 1,001,870 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.05 per share. 17 Jul 2023 151,450 650,600 - 3.1 461,923 Common Stock
Iain D. Dukes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 19,500 19,500 - - Stock Option (right to buy)
Iain D. Dukes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 3,250 3,250 - - Restricted Stock Unit
Steven H. Stein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 3,250 3,250 - - Restricted Stock Unit
Steven H. Stein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 19,500 19,500 - - Stock Option (right to buy)
Donald J. Hayden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 19,500 19,500 - - Stock Option (right to buy)
Kathy Yi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 3,250 3,250 - - Restricted Stock Unit
Kathy Yi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 19,500 19,500 - - Stock Option (right to buy)
Donald J. Hayden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 3,250 3,250 - - Restricted Stock Unit
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 3,250 3,250 - - Restricted Stock Unit
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 19,500 19,500 - - Stock Option (right to buy)
David Kerstein Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 17,500 17,500 - - Restricted Stock Units
Timothy P. Clackson Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 45,625 45,625 - - Restricted Stock Units
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 17,500 17,500 - - Restricted Stock Units
William C. Shakespeare See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 21,250 21,250 - - Restricted Stock Units
Victor M. Rivera Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 16,250 16,250 - - Restricted Stock Units
Victor M. Rivera Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 97,500 97,500 - - Stock Option (right to buy)
Timothy P. Clackson Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 273,750 273,750 - - Stock Option (right to buy)
David Kerstein Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 105,000 105,000 - - Stock Option (right to buy)
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 105,000 105,000 - - Stock Option (right to buy)
William C. Shakespeare See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Feb 2023 127,500 127,500 - - Stock Option (right to buy)
Donald J. Hayden Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 29 Dec 2022 100 100 - 5 500 Common Stock
Donald J. Hayden Director Purchase of securities on an exchange or from another person at price $ 5.00 per share. 29 Dec 2022 9,900 10,000 - 5.0 49,489 Common Stock
Bradford D. Dahms Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 6.66 per share. 30 Nov 2022 1,502 6,142 - 6.7 10,000 Common Stock
Timothy P. Clackson Director, President and CEO Purchase of securities on an exchange or from another person at price $ 6.80 per share. 11 Nov 2022 2,500 351,030 - 6.8 16,995 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 5.21 per share. 07 Nov 2022 192,000 16,734,518 - 5.2 1,000,320 Common Stock
Steven H. Stein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2022 60,000 60,000 - - Stock Option (right to buy)
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 30,000 30,000 - - Stock Option (right to buy)
Iain D. Dukes Director, Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 15,000 15,000 - - Stock Option (right to buy)
Iain D. Dukes Director, Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 30,000 30,000 - - Stock Option (right to buy)
Kathy Yi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 30,000 30,000 - - Stock Option (right to buy)
Donald J. Hayden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2022 60,000 60,000 - - Stock Option (right to buy)
William C. Shakespeare See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 180,000 180,000 - - Stock Option (right to buy)
Victor M. Rivera Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 130,000 130,000 - - Stock Option (right to buy)
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 150,000 150,000 - - Stock Option (right to buy)
David Kerstein Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 150,000 150,000 - - Stock Option (right to buy)
David C. Dalgarno Chief Technical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 130,000 130,000 - - Stock Option (right to buy)
Timothy P. Clackson Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 450,000 450,000 - - Stock Option (right to buy)
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.06 per share. 11 Jan 2022 18,897 16,366,915 - 10.1 190,104 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.43 per share. 11 Jan 2022 17,320 16,384,235 - 9.4 163,328 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 10.67 per share. 11 Jan 2022 6,900 16,348,018 - 10.7 73,623 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 9.81 per share. 11 Jan 2022 1,600 16,341,118 - 9.8 15,696 Common Stock
Bradford D. Dahms Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 10.15 per share. 21 Dec 2021 1,970 1,970 - 10.2 20,000 Common Stock
Timothy P. Clackson Director, President and CEO Purchase of securities on an exchange or from another person at price $ 9.76 per share. 21 Dec 2021 2,600 348,530 - 9.8 25,381 Common Stock
William C. Shakespeare See Remarks Purchase of securities on an exchange or from another person at price $ 16.00 per share. 12 Oct 2021 625 388,949 - 16 10,000 Common Stock
Carl L Gordon Director, Ten Percent Owner 12 Oct 2021 14,903,718 0 - - Series A Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner 12 Oct 2021 873,300 0 - - Series B Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner 12 Oct 2021 436,650 0 - - Series B Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 12 Oct 2021 562,500 16,339,518 - 16 9,000,000 Common Stock
Carl L Gordon Director, Ten Percent Owner 12 Oct 2021 436,650 436,650 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 12 Oct 2021 15,777,018 15,777,018 - - Common Stock
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 16.00 per share. 12 Oct 2021 62,500 499,150 - 16 1,000,000 Common Stock
Kathy Yi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 22,678 22,678 - - Stock Option (right to buy)
Iain D. Dukes Director, Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 22,678 22,678 - - Stock Option (right to buy)
Carl L Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2021 22,678 22,678 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters